Volume 44, Issue 5, Pages (May 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Angiogenesis and hepatocellular carcinoma
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
by Valerie V. Kupriyanov, Laura C
Michiko Tashiro, Hana Inoue, Masato Konishi  Biophysical Journal 
Therapeutic delivery of hydrogen sulfide for salvage of ischemic skeletal muscle after the onset of critical ischemia  Peter W. Henderson, MD, Natalia.
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: Rationale, current evidence and future directions 
Reactive oxygen species in the normal and acutely injured liver
Volume 41, Issue 6, Pages (December 2004)
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 44, Issue 6, Pages (June 2006)
Impaired glycolytic metabolism causes chondrocyte hypertrophy-like changes via promotion of phospho-Smad1/5/8 translocation into nucleus  T. Nishida,
Volume 44, Issue 4, Pages (April 2006)
Volume 42, Issue 3, Pages (March 2005)
Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis by Raymond J. Coakley, Clifford Taggart,
Volume 42, Issue 1, Pages (January 2005)
Volume 41, Issue 3, Pages (September 2004)
Volume 39, Issue 3, Pages (September 2003)
Volume 42, Issue 4, Pages (April 2005)
Living donor liver transplantation: is the hype over?
Volume 63, Issue 1, Pages (July 2015)
Volume 44, Issue 1, Pages (January 2006)
Volume 42, Issue 1, Pages (January 2005)
Volume 44, Issue 3, Pages (March 2006)
Volume 42, Issue 6, Pages (June 2005)
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 42, Issue 2, Pages (February 2005)
Angiogenesis and hepatocellular carcinoma
Why men are at higher risk for hepatocellular carcinoma?
Volume 62, Issue 3, Pages (March 2015)
Ribavirin ante portas: Uptake transporters into hepatocytes dissected
Volume 44, Issue 4, Pages (April 2006)
Volume 129, Issue 2, Pages (August 2005)
Volume 59, Issue 3, Pages (September 2013)
JNK mediates hepatic ischemia reperfusion injury
George T. Kannarkat, Dean J. Tuma, Pamela L. Tuma 
Volume 41, Issue 3, Pages (September 2004)
Volume 56, Issue 4, Pages (April 2012)
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 62, Issue 6, Pages (June 2015)
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Superoxide-induced apoptosis of activated rat hepatic stellate cells
Edmund J. Crampin, Nicolas P. Smith  Biophysical Journal 
L. -C. Chu, M. -L. Tsaur, C. -S. Lin, Y. -C. Hung, T. -Y. Wang, C. -C
Gallstones: Bad Company for the Steatotic Liver
Volume 42, Issue 2, Pages (February 2005)
Dale A Parks, Kelly A Skinner, Henry B Skinner, Sidhartha Tan 
The start of a new era in bile physiology
Volume 41, Issue 6, Pages (December 2004)
Liver stem cells—prospects for clinical use
Controlled hyperkalemic reperfusion with magnesium rescues ischemic juvenile hearts by reducing calcium loading  Hajime Imura, MD, Hua Lin, MSc, Elinor.
Volume 7, Issue 3, Pages (May 2014)
Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors  Shixiong Liao, MSa, Manuel.
Raúl A. Marinelli, Pamela S. Tietz, Nicholas F. LaRusso 
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis
Volume 63, Issue 1, Pages (July 2015)
Volume 8, Issue 3, Pages (June 2002)
Volume 64, Issue 1, Pages (January 2016)
Manfred Bilzer, Gustav Paumgartner, Alexander L. Gerbes 
Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia  Vivek Rao, MD, PhD, Frank Merante, PhD,
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Bill Andriopoulos, Kostas Pantopoulos  Journal of Hepatology 
Woo-Yong Lee, Paul Kubes  Journal of Hepatology 
Presentation transcript:

Volume 44, Issue 5, Pages 894-901 (May 2006) Role of pH in protection by low sodium against hypoxic injury in isolated perfused rat livers  Mariapia Vairetti, Plinio Richelmi, Francantonio Bertè, Robert T. Currin, John J. Lemasters, Roberto Imberti  Journal of Hepatology  Volume 44, Issue 5, Pages 894-901 (May 2006) DOI: 10.1016/j.jhep.2005.08.007 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Protection of isolated rat livers by low-Na+ KHB during hypoxic perfusion. In normoxic control experiments, rat livers were perfused with KHB (●) or low-Na+ KHB (▪) equilibrated with 95% O2 and 5% CO2. During hypoxia, livers were perfused with KHB (○) or with low-Na+ KHB (▪) equilibrated with 95% N2 and 5% CO2. At 10-min intervals, LDH activity of the effluent perfusate was determined. During hypoxia, LDH release was higher with KHB than with low-Na+ KHB (P< 0.05, 4–6 perfusions per group). Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Accelerated injury after replacement of low-Na+ KHB with KHB during hypoxic perfusion. Isolated livers were perfused with KHB (○) or low-Na+ KHB (□) equilibrated with 95% N2 and 5% CO2. After 40min (arrow), low-Na+ KHB was replaced with KHB (σ). At 10-min intervals, LDH activity of the effluent perfusate was determined (4–6 perfusions per group). Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Effects of hypoxic liver perfusion on bile flow. Rat livers were perfused with the KHB (●,○) or low-Na+ KHB (▪,□), and bile was collected at 10-min intervals. During normoxia (●,▪), bile production (area under the curve) was higher with KHB than low-Na+ KHB, whereas after longer than 20min of hypoxia (○,□), bile production was greater in low-Na+ KHB (P<0.05, 4–6 perfusions per group). Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Effects of hypoxic perfusion on liver tissue ATP. Rat livers were perfused with low-Na+ KHB (black bars) and KHB (grey bars) and tissue ATP measured at indicated time points (*P<0.05, 4–5 perfusions per group). Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Effects of mannitol and sucrose on LDH release during hypoxic liver perfusion. Isolated livers were perfused with KHB (○), with KHB containing 150mM mannitol (▿) or with KHB containing 150 mM sucrose (▾). At 10-min intervals, LDH activity of the effluent perfusate was determined. LDH release (area under the curve) was lower during KHB plus mannitol than KHB plus sucrose or KHB alone (P<0.05, 4–6 perfusions per group). Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Liver weight after hypoxic liver perfusion. Livers were weighed at the end of perfusions and compared with their initial weight estimated from body weight, as described in Section 2. *P<0.05 versus KHB perfusion (4–6 perfusions per group). N.S.=non-significant. Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Reversal by monensin of protection by low-Na+ KHB during hypoxic perfusion of isolated rat livers. Livers were perfused under hypoxic conditions with KHB for 120min (○), low-Na+ KHB at pH 7.4 for 120min (□), low-Na+ KHB at pH 7.4 with the addition of monensin (0.2μM, arrow) after 40min (♢), or low-Na+ KHB at pH 6.8 with the addition of monensin (0.2μM, arrow) after 40min (♦). At 10-min intervals, LDH activity of the effluent perfusate was determined. LDH release (area under the curve) was significantly higher with low-Na+ KHB plus monensin at pH 7.4 than with low-Na+ KHB plus monensin at pH 6.8 (P<0.01, 4–6 perfusions per group). Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 8 Effects of monensin on intracellular pH during hypoxic liver perfusion with low-Na+ KHB at normal and acidotic pH. Isolated livers were first perfused for 20min with normoxic KHB at pH 7.4. At time 0, the perfusate was changed to hypoxic low-Na+ KHB at pH 7.4 (●) or 6.8 (○). Intracellular pH was measured by confocal ratio imaging of BCECF fluorescence, as described in Section 2. Monensin (5μM) was added to the perfusate after 40min. Before monensin, intracellular pH (area under the curve) was greater at pH 7.4 than pH 6.8 (P<0.05). After monensin, intracellular pH was greater at an extracellular of pH 7.4 than pH 6.8 (P<0.01). Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 9 Trypan blue uptake after perfusion with KHB and low-Na+ KHB. After 40min of perfusion, livers were infused with trypan blue, fixed and prepared for histology, as described in Section 2. No trypan blue uptake occurred after aerobic perfusion with standard KHB (A) or low-Na+ KHB (B). After 40min of hypoxic perfusion with standard KHB, both parenchymal and non-parenchymal cells took up trypan blue (C). Perfusion with low-Na+ KHB protected parenchymal cells against hypoxia, but did not spare non-parenchymal cells (D). Eosin, magnification ×400. Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 10 Proposed mechanism of prevention of cell death by low-Na+ KHB during hypoxic liver injury. Low-Na+ KHB inhibits Na/H+ exchange and Na+/HCO3- co-transport, thus preventing intracellular alkalinization and pH-dependent cell death. Arrows labeled “-”indicate inhibitory effects. Journal of Hepatology 2006 44, 894-901DOI: (10.1016/j.jhep.2005.08.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions